57 related articles for article (PubMed ID: 15249855)
1. A study of collagen refractility in dermatofibroma and dermatofibrosarcoma protuberans using diffractive microscopy.
Brailsford C; Khamdan F; Dirr MA; Sagut P; Nietert PJ; Elston D
J Cutan Pathol; 2024 Apr; 51(4):306-310. PubMed ID: 38124386
[TBL] [Abstract][Full Text] [Related]
2. Connexin 43 in Dermatofibroma and Dermatofibrosarcoma Protuberans: Diagnostic, Pathogenic, and Therapeutic Implications.
Fernandez-Flores A; Varela-Vazquez A; Mayan MD; Fonseca E
Am J Dermatopathol; 2023 Dec; 45(12):812-815. PubMed ID: 37982464
[TBL] [Abstract][Full Text] [Related]
3. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors.
Georgantzoglou N; Linos K
Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655
[TBL] [Abstract][Full Text] [Related]
4. High Mobility Group A proteins in esophageal carcinomas.
Palumbo Júnior A; Da Costa NM; Esposito F; Fusco A; Pinto LF
Cell Cycle; 2016 Sep; 15(18):2410-3. PubMed ID: 27484584
[TBL] [Abstract][Full Text] [Related]
5. The Burden of Skin Cancers in Saudi Arabia Through 2011-2022.
AlOtaibi MN; Basfar AS; Jawhari AM; Alzahrani ES; Althomali MA; Alhindi AE; Alam SS; Al Aboud DM; Abdel-Moneim AS
Cureus; 2023 Sep; 15(9):e45052. PubMed ID: 37829962
[TBL] [Abstract][Full Text] [Related]
6. 168 Cases of aneurysmal dermatofibroma and 29 cases of hemosiderotic dermatofibroma: A clinicopathologic study.
Nishimoto A; Ito K; Usami S; Ogawa R; Akaishi S; Ansai SI
Am J Clin Pathol; 2024 Mar; 161(3):232-244. PubMed ID: 37897209
[TBL] [Abstract][Full Text] [Related]
7. Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis.
D'Angelo D; De Martino M; Arra C; Fusco A
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31487906
[TBL] [Abstract][Full Text] [Related]
8. Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases.
Dreux N; Marty M; Chibon F; Vélasco V; Hostein I; Ranchère-Vince D; Terrier P; Coindre JM
Mod Pathol; 2010 Dec; 23(12):1657-66. PubMed ID: 20834238
[TBL] [Abstract][Full Text] [Related]
9. Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis.
Wang Q; Chen F; He Y; Gao Y; Wang J; Chu S; Xie P; Zhong J; Shan H; Bai J; Hou P
iScience; 2024 Mar; 27(3):109158. PubMed ID: 38405614
[TBL] [Abstract][Full Text] [Related]
10. Bednar's tumor at right shoulder in an adult male: a case report of a rare entity.
Acharya B; Yadav DK; Chetry A; Chhetri P; Chhetri P; Shah D
Ann Med Surg (Lond); 2024 Feb; 86(2):1196-1199. PubMed ID: 38333248
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis.
Hussein MRA; Abdelwahed Hussein TMR
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36672995
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans of the breast: A case report.
Pohlodek K; Mečiarová I; Grossmann P; Kinkor Z
Oncol Lett; 2017 Jul; 14(1):993-998. PubMed ID: 28693264
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
16. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
[TBL] [Abstract][Full Text] [Related]
17. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
Goldblum JR; Tuthill RJ
Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
[TBL] [Abstract][Full Text] [Related]
18. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
